Skip to main navigation
Skip to search
Skip to main content
UNIC | Research Portal Home
Search content at UNIC | Research Portal
Home
Profiles
Research units
Research output
Projects
Anti-HBs response in seroconverting chronic HBV carriers following alpha-interferon treatment
P. Karayiannis
, S. Kanatakis
, H. C. Thomas
Medical School
Imperial College London
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Anti-HBs response in seroconverting chronic HBV carriers following alpha-interferon treatment'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Interferon-α (IFN-α)
100%
Hepatitis B Carrier
100%
Chronic Hepatitis B Virus
100%
Hepatitis B Surface Antigen (HBsAg)
100%
Interferon Treatment
100%
Acute Infection
25%
Infected Patients
25%
Hepatitis B Vaccine
25%
Hospital Personnel
25%
Antibody Response
25%
Plasma-derived
25%
Convalescent
25%
Immunology and Microbiology
Virus Carrier
100%
Hepatitis B Virus
100%
Interferon Alfa
100%
Hepatitis B Surface Antibody
100%
HBsAg
33%
Hepatitis B Antigen
33%
Blood Plasma
33%
Antibody Response
33%
Virus Vaccine
33%
Biochemistry, Genetics and Molecular Biology
Virus Carrier
100%
Hepatitis B Virus
100%
Interferon
100%
HBsAg
33%
Antibody Response
33%
Blood Plasma
33%